Literature DB >> 12654836

An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.

Annette K Møller1, Mary P Leatham, Tyrrell Conway, Piet J M Nuijten, Louise A M de Haan, Karen A Krogfelt, Paul S Cohen.   

Abstract

The ability of E. coli strains to colonize the mouse large intestine has been correlated with their ability to grow in cecal and colonic mucus. In the present study, an E. coli MG1655 strain was mutagenized with a mini-Tn5 Km (kanamycin) transposon, and mutants were tested for the ability to grow on agar plates with mouse cecal mucus as the sole source of carbon and nitrogen. One mutant, designated MD42 (for mucus defective), grew poorly on cecal-mucus agar plates but grew well on Luria agar plates and on glucose minimal-agar plates. Sequencing revealed that the insertion in MD42 was in the waaQ gene, which is involved in lipopolysaccharide (LPS) core biosynthesis. Like "deep-rough" E. coli mutants, MD42 was hypersensitive to sodium dodecyl sulfate (SDS), bile salts, and the hydrophobic antibiotic novobiocin. Furthermore, its LPS core oligosaccharide was truncated, like that of a deep-rough mutant. MD42 initially grew in the large intestines of streptomycin-treated mice but then failed to colonize (<10(2) CFU per g of feces), whereas its parent colonized at levels between 10(7) and 10(8) CFU per g of feces. When mouse cecal mucosal sections were hybridized with an E. coli-specific rRNA probe, MD42 was observed in cecal mucus as clumps 24 h postfeeding, whereas its parent was present almost exclusively as single cells, suggesting that clumping may play a role in preventing MD42 colonization. Surprisingly, MD42 grew nearly as well as its parent during growth in undiluted, highly viscous cecal mucus isolated directly from the mouse cecum and, like its parent, survived well after reaching stationary phase, suggesting that there are no antimicrobials in mucus that prevent MD42 colonization. After mini-mariner transposon mutagenesis, an SDS-resistant suppressor mutant of MD42 was isolated. The mini-mariner insertion was shown to be in the bipA gene, a known regulator of E. coli surface components. When grown in Luria broth, the LPS core of the suppressor mutant remained truncated; however, the LPS core was not truncated when the suppressor mutant was grown in the presence of SDS. Moreover, when the suppressor mutant was grown in the presence of SDS and fed to mice, it colonized the mouse large intestine. Collectively, the data presented here suggest that BipA may play a role in E. coli MG1655 LPS core biosynthesis and that because MD42 forms clumps in intestinal mucus, it is unable to colonize the mouse large intestine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654836      PMCID: PMC152069          DOI: 10.1128/IAI.71.4.2142-2152.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Effect of rfaH (sfrB) and temperature on expression of rfa genes of Escherichia coli K-12.

Authors:  E Pradel; C A Schnaitman
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

2.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

3.  Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects.

Authors:  K A Krogfelt; P Klemm
Journal:  Microb Pathog       Date:  1988-03       Impact factor: 3.738

4.  Bacterial adhesion to and penetration of intestinal mucus in vitro.

Authors:  P S Cohen; D C Laux
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.

Authors:  B A McCormick; B A Stocker; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine.

Authors:  B A McCormick; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.

Authors:  K A Krogfelt; L K Poulsen; S Molin
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization.

Authors:  L K Poulsen; F Lan; C S Kristensen; P Hobolth; S Molin; K A Krogfelt
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine.

Authors:  J V Newman; R Kolter; D C Laux; P S Cohen
Journal:  Microb Pathog       Date:  1994-11       Impact factor: 3.738

10.  Salmonella typhimurium responses to a bactericidal protein from human neutrophils.

Authors:  S Y Qi; Y Li; A Szyroki; I G Giles; A Moir; C D O'Connor
Journal:  Mol Microbiol       Date:  1995-08       Impact factor: 3.501

View more
  49 in total

1.  Genotype and phenotypes of an intestine-adapted Escherichia coli K-12 mutant selected by animal passage for superior colonization.

Authors:  Andrew J Fabich; Mary P Leatham; Joe E Grissom; Graham Wiley; Hongshing Lai; Fares Najar; Bruce A Roe; Paul S Cohen; Tyrrell Conway
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.

Authors:  Mary P Leatham; Sarah J Stevenson; Eric J Gauger; Karen A Krogfelt; Jeremy J Lins; Traci L Haddock; Steven M Autieri; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Commensal and Pathogenic Escherichia coli Metabolism in the Gut.

Authors:  Tyrrell Conway; Paul S Cohen
Journal:  Microbiol Spectr       Date:  2015-06

4.  Metabolism and Fitness of Urinary Tract Pathogens.

Authors:  Christopher J Alteri; Harry L T Mobley
Journal:  Microbiol Spectr       Date:  2015-06

5.  Role of porins in sensitivity of Escherichia coli to antibacterial activity of the lactoperoxidase enzyme system.

Authors:  Philipp De Spiegeleer; Jan Sermon; Kristof Vanoirbeek; Abram Aertsen; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 6.  Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments.

Authors:  Christopher J Alteri; Harry L T Mobley
Journal:  Curr Opin Microbiol       Date:  2011-12-27       Impact factor: 7.934

7.  The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.

Authors:  Mary P Leatham-Jensen; Jakob Frimodt-Møller; Jimmy Adediran; Matthew E Mokszycki; Megan E Banner; Joyce E Caughron; Karen A Krogfelt; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

8.  Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine.

Authors:  Shari A Jones; Mathias Jorgensen; Fatema Z Chowdhury; Rosalie Rodgers; James Hartline; Mary P Leatham; Carsten Struve; Karen A Krogfelt; Paul S Cohen; Tyrrell Conway
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.

Authors:  Regina L Miranda; Tyrrell Conway; Mary P Leatham; Dong Eun Chang; Wendy E Norris; James H Allen; Sarah J Stevenson; David C Laux; Paul S Cohen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.

Authors:  M-L Foucault; L Thomas; S Goussard; B R Branchini; C Grillot-Courvalin
Journal:  Appl Environ Microbiol       Date:  2009-10-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.